MarkNtel Advisors recently published a detailed industry analysis of the Drug Screening Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.
Insights and Analysis of the Drug Screening Market (2025-2030)
The Global Drug Screening Market size was valued at USD 7.5 billion in 2022 and is projected to grow at a CAGR of around 11.33% during the forecast period, i.e., 2025-30.
Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/drug-screening-market.html
What is driving the Drug Screening market?
The Surge in Drug and Alcohol Consumption – According to the World Drug Report 2021 released by the United Nations Office on Drugs and Crime (UNODC) in 2022, there has been a significant 22% rise in the number of drug users worldwide. Similarly, The UNODC’s findings in 2021 revealed that approximately 200 million individuals, accounting for 4% of the global population, were cannabis users. Moreover, the number of cannabis users witnessed an 18% increase. Additionally, around 20 million people, representing 0.4% of the global population, were reported to have consumed cocaine.
According to WHO, Cannabis continues to be the most prevalent illicit substance in the African Region, with West and Central Africa experiencing the highest rates of use and witnessing an alarming increase. Reported prevalence in this region ranges from 5.2% to 13.5%. As drug consumption continues to escalate among the population, the demand for drug screening services is projected to soar, subsequently fostering substantial market growth during the study period.
What segments define the Drug Screening market from 2025 to 2030? How do these segments contribute to market dynamics and growth?
By Type
(Manual, Semi-Automatic, Automatic),
By Product
(<1.0 ml, 1.1ml-2.5ml, 2.6 ml-5.0ml, >5.0ml),
By Material
(Glass, Plastic),
By End Users
(Hospitals, Clinics, Others),
By Region
(North America, South America, Europe, The Middle East & Africa, Asia-Pacific)
Explore the Complete Drug Screening Market Analysis Report – https://www.marknteladvisors.com/research-library/drug-screening-market.html
Who are the leading key players shaping the Drug Screening Market landscape?
Labcorp, Quest Diagnostics, Abbott Laboratories, Orasure Technologies, Alfa Scientific Designs, ThermoFisher Scientific, Dragewerk, Lifeloc Technologies, MPD Inc., Omega Laboratories, Premier Biotech, Psychmedics, Siemens Healthineers, Shimadzu Corporation, Hoffmann-La Roche Ltd., Others
Questions Addressed in this Study
1.What factors are driving the Drug Screening Market growth?
2.How is the Drug Screening Market expected to grow over the next five years?
3.What are the key insights into the current trends in the Drug Screening Market?
4.What is the current size of the Drug Screening Market, and how is it projected to change in the future?
6.What is the future outlook for the Drug Screening Market in terms of technological advancements and market expansion?
For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/drug-screening-market.html
Why MarkNtel Advisors?
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
